Heparin dose during percutaneous coronary intervention: how low dare we go?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 12231583.
- Also identified by PMC identifier 1767377.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Despite dramatic advances in percutaneous coronary intervention, including coronary stents and potent antiplatelet agents, unfractionated heparin remains the standard procedural anticoagulant. Tradition and habit may have considerable influence over dose selection. A review of the role and dosage of heparin during PCI appears to be overdue
Medical subject headings
- Angioplasty, Balloon, Coronary
- Anticoagulants
- Heparin